Anti-angiogenic action of the C-terminal domain of tenomodulin that shares homology with chondromodulin-I
- PMID: 15150318
- DOI: 10.1242/jcs.01112
Anti-angiogenic action of the C-terminal domain of tenomodulin that shares homology with chondromodulin-I
Abstract
Tenomodulin (TeM) is a type II transmembrane glycoprotein that contains a C-terminal domain with homology to the mature, secreted form of chondromodulin-I (ChM-I), a cartilage-derived angiogenesis inhibitor. TeM transcripts have been found in hypovascular tissues such as tendons and ligaments but the biological activity of TeM has not yet been fully explored. Using an adenovirus expression system, we utilized the forced expression and subsequent secretion of the human TeM C-terminal 116 amino acids (Ad-shTeM) in human umbilical vein endothelial cells (HUVECs) to assess the anti-angiogenic properties of TeM. The C-terminal 120 amino acids of the human ChM-I precursor (Ad-shChM-I) was similarly expressed in HUVECs as a comparison study. Transduction of both Ad-shTeM and Ad-shChM-I resulted in significant impairment of the tube-forming activity of HUVECs, when cultured in Matrigel. Similarly, conditioned medium from COS7 cells, transfected with plasmid DNA encoding shTeM or shChM-I, inhibited tube formation of HUVECs when compared to medium derived from either COS7 cells transfected with control vector or from non-transfected cells. Upon infection of HUVECs with Ad-shTeM or Ad-shChM-I, DNA synthesis stimulated by vascular endothelial growth factor (VEGF) was reduced to 40-50% of normal levels. Additionally, in a modified Boyden chamber assay, migration of HUVECs in response to VEGF was significantly affected following transduction of either Ad-shTeM or Ad-shChM-I and these transduced HUVECs were found to spread well on type I collagen or fibronectin, but not on vitronectin. Furthermore, the transduction of either Ad-shTeM or Ad-shChM-I in human melanoma cells resulted in suppression of tumor growth in association with decreased vessel density in vivo. Hence, we have demonstrated that, similarly to ChM-1, the C-terminal domain of TeM exhibits both anti-angiogenic and anti-tumor activities when expressed in a secreted form.
Similar articles
-
Chondromodulin-I and tenomodulin: the negative control of angiogenesis in connective tissue.Curr Pharm Des. 2007;13(20):2101-12. doi: 10.2174/138161207781039751. Curr Pharm Des. 2007. PMID: 17627542 Review.
-
Impairment of VEGF-A-stimulated lamellipodial extensions and motility of vascular endothelial cells by chondromodulin-I, a cartilage-derived angiogenesis inhibitor.Exp Cell Res. 2010 Mar 10;316(5):775-88. doi: 10.1016/j.yexcr.2009.12.009. Epub 2009 Dec 21. Exp Cell Res. 2010. PMID: 20026108
-
Expression and localization of tenomodulin, a transmembrane type chondromodulin-I-related angiogenesis inhibitor, in mouse eyes.Invest Ophthalmol Vis Sci. 2003 May;44(5):1814-23. doi: 10.1167/iovs.02-0664. Invest Ophthalmol Vis Sci. 2003. PMID: 12714610
-
Synthetic disulfide-bridged cyclic peptides mimic the anti-angiogenic actions of chondromodulin-I.Cancer Sci. 2012 Jul;103(7):1311-8. doi: 10.1111/j.1349-7006.2012.02276.x. Epub 2012 Apr 27. Cancer Sci. 2012. PMID: 22429838 Free PMC article.
-
Angiogenesis inhibitors localized in hypovascular mesenchymal tissues: chondromodulin-I and tenomodulin.Connect Tissue Res. 2005;46(1):3-11. doi: 10.1080/03008200590935547. Connect Tissue Res. 2005. PMID: 16019413 Review.
Cited by
-
A functional role of the glycosylated N-terminal domain of chondromodulin-I.J Bone Miner Metab. 2011 Jan;29(1):23-30. doi: 10.1007/s00774-010-0193-0. Epub 2010 May 27. J Bone Miner Metab. 2011. PMID: 20506028
-
Single nucleotide polymorphisms of the tenomodulin gene (TNMD) in age-related macular degeneration.Mol Vis. 2009;15:762-70. Epub 2009 Apr 15. Mol Vis. 2009. PMID: 19381347 Free PMC article.
-
Scleraxis is a transcriptional activator that regulates the expression of Tenomodulin, a marker of mature tenocytes and ligamentocytes.Sci Rep. 2018 Feb 16;8(1):3155. doi: 10.1038/s41598-018-21194-3. Sci Rep. 2018. PMID: 29453333 Free PMC article.
-
Vascularization as a potential enemy in valvular heart disease.Circulation. 2008 Oct 21;118(17):1694-6. doi: 10.1161/CIRCULATIONAHA.108.809475. Circulation. 2008. PMID: 18936337 Free PMC article. No abstract available.
-
Identification and Distinction of Tenocytes and Tendon-Derived Stem Cells.Front Cell Dev Biol. 2021 Apr 16;9:629515. doi: 10.3389/fcell.2021.629515. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33937230 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous